The Editorial Position on ‘Recent Advances in Multifunctional Antimicrobial Peptides as Preclinical Therapeutic Studies and Clinical Future Applications’-Reference-Cited by-同舟云学术

The Editorial Position on ‘Recent Advances in Multifunctional Antimicrobial Peptides as Preclinical Therapeutic Studies and Clinical Future Applications’

Published:2023-09-26 Issue:10 Volume:15 Page:2383
ISSN:1999-4923
Container-title:Pharmaceutics
language:en
Short-container-title:Pharmaceutics

Author:

Scavello Francesco¹^ORCID,Amiche Mohamed²^ORCID,Ghia Jean-Eric³⁴

Affiliation:

1. IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy

2. Laboratoire de Biogenèse des Signaux Peptidiques (BioSiPe), Institut de Biologie Paris-Seine, Sorbonne Université-CNRS, 75252 Paris, France

3. Department of Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0T5, Canada

4. Section of Gastroenterology, Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0T5, Canada

Abstract

Antibiotic resistance has recently been recognized as an alarming issue and one of the leading causes of death worldwide [...]

Publisher

MDPI AG

Subject

Pharmaceutical Science

Link

https://www.mdpi.com/1999-4923/15/10/2383/pdf

Reference34 articles.

1. Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet, 399, 629–655.

2. Antimicrobial resistance in patients with COVID-19: A systematic review and meta-analysis;Langford;Lancet Microbe,2023

3. The value of antimicrobial peptides in the age of resistance;Magana;Lancet Infect. Dis.,2020

4. Schneider, F., Clère-Jehl, R., Scavello, F., Lavigne, T., Corti, A., Angelone, T., Haïkel, Y., and Lavalle, P. (2022). Chromogranin A and Its Fragments in the Critically Ill: An Expanding Domain of Interest for Better Care. Pharmaceutics, 14.

5. Aslam, R., Marban, C., Corazzol, C., Jehl, F., Delalande, F., Van Dorsselaer, A., Prévost, G., Haïkel, Y., Taddei, C., and Schneider, F. (2013). Cateslytin, a chromogranin A derived peptide is active against Staphylococcus aureus and resistant to degradation by its proteases. PLoS ONE, 8.